Protagonist Therapeutics Inc buy Jefferies Financial Group Inc.
Start price
02.02.26
/
50%
€70.50
Target price
02.02.27
€99.38
Performance (%)
65.96%
Price
29.07.26
€117.00
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Protagonist Therapeutics Inc has seen massive gains of 65.96%. This prediction currently runs until 02.02.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -1.681% | -1.681% |
| iShares Core DAX® | 3.901% | 2.667% |
| iShares Nasdaq 100 | -2.603% | -7.934% |
| iShares Nikkei 225® | -0.545% | -9.754% |
| iShares S&P 500 | -0.881% | -1.488% |
Comments by Jefferies_Financial_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Jefferies Financial Group Inc. from $95.00 to $118.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€85.00
18.03.26
18.03.26
-
18.03.27
18.03.27
37.65%
29.07.26
29.07.26
